Nelfinavir suppresses insulin signaling and nitric oxide production by human aortic endothelial cells: protective effects of thiazolidinediones

about

Nelfinavir suppresses insulin signaling and nitric oxide production by human aortic endothelial cells: protective effects of thiazolidinediones

Item

http://www.wikidata.org/entity/Q36701580

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Nelfinavir suppresses insulin ...... effects of thiazolidinediones

@ast

Nelfinavir suppresses insulin ...... effects of thiazolidinediones

@en

type

Item

label

Nelfinavir suppresses insulin ...... effects of thiazolidinediones

@ast

Nelfinavir suppresses insulin ...... effects of thiazolidinediones

@en

prefLabel

Nelfinavir suppresses insulin ...... effects of thiazolidinediones

@ast

Nelfinavir suppresses insulin ...... effects of thiazolidinediones

@en

P1476

Nelfinavir suppresses insulin ...... effects of thiazolidinediones

@en

P2093

Debasis Mondal

http://www.w3.org/2001/XMLSchema#string

Joseph A Lasky

http://www.w3.org/2001/XMLSchema#string

Kai Liu

http://www.w3.org/2001/XMLSchema#string

Krishna C Agrawal

http://www.w3.org/2001/XMLSchema#string

Milton Hamblin

http://www.w3.org/2001/XMLSchema#string

P2860

PPARs and the cardiovascular system

Effect of rosiglitazone and metformin on insulin resistance in patients infected with human immunodeficiency virus receiving highly active antiretroviral therapy containing protease inhibitor: randomized prospective controlled clinical trial

Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?

Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study.

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone.

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis.

Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo.

Endothelial dysfunction: a marker of atherosclerotic risk.

P304

76-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23533049

http://www.w3.org/2001/XMLSchema#string

P921

endothelium

P932

3603192

http://www.w3.org/2001/XMLSchema#string